NCT07179627 Ankle Exoskeleton for Stroke Gait Enhancement
| NCT ID | NCT07179627 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Georgia Institute of Technology |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2026-02-09 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2026-02-09 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This work will focus on new algorithms for robotic ankle exoskeletons and testing these in human subject tests. Individuals who have previously had a stroke will walk while wearing a robotic exoskeleton on a specialized treadmill as well as during other movement tasks (e.g., overground, stairs, ramps). The study will compare the performance of the advanced algorithm with not using the device to determine the clinical benefit.
Eligibility Criteria
Inclusion Criteria: * Between 18-85 years of age * Had a stroke at least 6 months prior to study involvement * Are community dwelling, which means you do not live in an assisted living facility * Are able to provide informed consent to participate in the study activities * Can safely participate in the study activities (per self-report) * Must have a Functional Ambulation Category (FAC) score of 3 or above, which means you can walk without the assistance of another person Exclusion Criteria: * Require a walker to walk independently * Have a shuffling gait pattern overground * Have a Functional Ambulation Category (FAC) score of 2 or lower, which means you require the assistance of another person in order to walk * Have a significant secondary deficit beyond stroke (e.g. amputation, legal blindness or other severe impairment or condition) that in the opinion of the Principal Investigator (PI), would likely affect the study outcome or confound the results * For exoskeleton-only studies, the exoskeleton device does not fit appropriately or safely, as determined by the research team during the fitting assessment.
Contact & Investigator
Aaron Young, PhD
PRINCIPAL INVESTIGATOR
Georgia Institute of Technology
Frequently Asked Questions
Who can join the NCT07179627 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07179627 currently recruiting?
Yes, NCT07179627 is actively recruiting participants. Contact the research team at aaron.young@me.gatech.edu for enrollment information.
Where is the NCT07179627 trial being conducted?
This trial is being conducted at Atlanta, United States.
Who is sponsoring the NCT07179627 clinical trial?
NCT07179627 is sponsored by Georgia Institute of Technology. The principal investigator is Aaron Young, PhD at Georgia Institute of Technology. The trial plans to enroll 15 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.